PHGDH

Chr 1

phosphoglycerate dehydrogenase

Also known as: 3-PGDH, 3PGDH, HEL-S-113, NLS, NLS1, PDG, PGAD, PGD

This gene encodes the enzyme which is involved in the early steps of L-serine synthesis in animal cells. L-serine is required for D-serine and other amino acid synthesis. The enzyme requires NAD/NADH as a cofactor and forms homotetramers for activity. Mutations in this gene have been found in a family with congenital microcephaly, psychomotor retardation and other symptoms. Multiple alternatively spliced transcript variants have been found, however the full-length nature of most are not known. [provided by RefSeq, Aug 2011]

GeneReviewsResearchGenerating clinical summary…
LOFmechanismLOEUF 0.78
Clinical SummaryPHGDH
🧬
Gene-Disease Validity (ClinGen)
neurometabolic disorder due to serine deficiency · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
106 unique Pathogenic / Likely Pathogenic· 314 VUS of 959 total submissions
📖
GeneReview available — PHGDH
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.78LOEUF
pLI 0.000
Z-score 2.34
OE 0.46 (0.280.78)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.21Z-score
OE missense 0.97 (0.881.06)
295 obs / 305.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.46 (0.280.78)
00.351.4
Missense OE?0.97 (0.881.06)
00.61.4
Synonymous OE?1.06
01.21.6
LoF obs/exp: 10 / 21.8Missense obs/exp: 295 / 305.2Syn Z: -0.57
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
moderatePHGDH-related Neu-Laxova syndromeOTHERAR
definitivePHGDH-related phosphoglycerate dehydrogenase deficiencyLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6649th %ile
GOF
0.4777th %ile
LOF
0.3648th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

959 submitted variants in ClinVar

Classification Summary

Pathogenic49
Likely Pathogenic57
VUS314
Likely Benign473
Benign28
Conflicting28
49
Pathogenic
57
Likely Pathogenic
314
VUS
473
Likely Benign
28
Benign
28
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
38
3
8
0
49
Likely Pathogenic
47
9
1
0
57
VUS
3
268
35
8
314
Likely Benign
0
3
206
264
473
Benign
0
0
25
3
28
Conflicting
28
Total88283275275949

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

9 pathogenic / likely-pathogenic (of 23) ClinVar copy-number / structural variants overlap PHGDH — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PHGDH · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →